Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of Early Stage Breast Cancer Patients With Abnormal Myocardial Deformation Treated With Anthracycline and/or Trastuzumab and Pertuzumab-based Cancer Therapy

NCT02993198 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT02993198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02993198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of Early Stage Breast Cancer Patients With Abnormal Myocardial Deformation Treated With Anthracycline and/or Trastuzumab and Pertuzumab-based Cancer Therapy
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2015
Completion date
December 31, 2025
Enrollment
134 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular abnormalities, her2 positive breast cancer